These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Use of mesenchymal stem cells (MSC) in chronic inflammatory fistulizing and fibrotic diseases: a comprehensive review. Voswinkel J; Francois S; Simon JM; Benderitter M; Gorin NC; Mohty M; Fouillard L; Chapel A Clin Rev Allergy Immunol; 2013 Oct; 45(2):180-92. PubMed ID: 23296948 [TBL] [Abstract][Full Text] [Related]
9. Role of epithelial cells in the pathogenesis and treatment of inflammatory bowel disease. Okamoto R; Watanabe M J Gastroenterol; 2016 Jan; 51(1):11-21. PubMed ID: 26138071 [TBL] [Abstract][Full Text] [Related]
10. Immune-mediated enteropathies: From bench to bedside. van Wanrooij RLJ; Bontkes HJ; Neefjes-Borst EA; Mulder CJ; Bouma G J Autoimmun; 2021 Mar; 118():102609. PubMed ID: 33607573 [TBL] [Abstract][Full Text] [Related]
11. Pre-activation of mesenchymal stem cells with TNF-α, IL-1β and nitric oxide enhances its paracrine effects on radiation-induced intestinal injury. Chen H; Min XH; Wang QY; Leung FW; Shi L; Zhou Y; Yu T; Wang CM; An G; Sha WH; Chen QK Sci Rep; 2015 Mar; 5():8718. PubMed ID: 25732721 [TBL] [Abstract][Full Text] [Related]
12. Chronic enteropathy and feeding. Salvatore S; Hauser B; Vandenplas Y Nestle Nutr Workshop Ser Pediatr Program; 2007; 59():115-26; discussion 126-31. PubMed ID: 17245095 [TBL] [Abstract][Full Text] [Related]